GlaxoSmithKline Chairman Philip Hampton bows out as company preps for split-up

21st January 2019 Uncategorised 0

Philip Hampton joined GlaxoSmithKline as chairman just as it upped the ante in consumer health with a Novartis joint venture. Now, he’s leaving, just as GSK is beefing up the unit in preparation for a company split-up.

More: GlaxoSmithKline Chairman Philip Hampton bows out as company preps for split-up
Source: fierce